About glp1ledger

GLP-1 medicines changed millions of lives and spawned an internet of hype, fear, and sales pitches. glp1ledger exists for the people in the middle: patients and families who want the evidence explained calmly.

We compare the medicines side by side from published trial data, explain what treatment really costs, and gather real-world experience — without ever pretending to be your doctor.

Every medical topic is reviewed for accuracy against its primary sources, and re-reviewed when new data lands. The date on the page tells you when.

glp1ledger is operated by Sherdas LLC. Contact: contact page.

Who works on glp1ledger

• Caroline S

  Editor

  Caroline S edits GLP1Ledger. She decides what the site covers, holds every page to the standard published on the methodology page before it runs, and is the person to write to about a correction.

• Ronald R

  Writer

  Ronald R covers the GLP-1 and metabolic-medicine beat: what these drugs are approved for, what the trials actually measured, what the labels say, what they cost, and how supply and policy keep moving underneath all of it.